Laurion Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-38,796	Closed	-$292K	–	416
2022 Q1	$292K	Sell	38,796 -27,374	-41%	-$206K	﹤0.01%	325
2021 Q4	$596K	Sell	66,170 -8,830	-12%	-$79.5K	0.01%	243
2021 Q3	$1.22M	Buy	+75,000	New	+$1.22M	0.01%	256